Olympios Papadimitriou holds the position of General Manager at Novo Nordisk Hellas LTD in the last 20 years. He started his career in the pharmaceutical sector in 1990, working as a sales representative at Wyeth (later absorbed by Pfizer), based in Thessaloniki. In less than a year, he joined Schering AG Berlin (later absorbed by Bayer). After completing a three-year term at Schering AG, he joined Novo Nordisk Hellas as a medical representative in 1994. He served for 6 years in the field of medical sales, and then for 5 years in the marketing department of diabetes. He became General Manager of Novo Nordisk Hellas in December 2005 Olympios Papadimitriou became a member of the SFEE Board of Directors in 2013, and as of March 2018 is the president of SFEE. He is a graduate of the German School of Thessaloniki and he also holds a Diploma in Chemistry from Aristotelion University of Thessaloniki. He has attended Young Manager’s Program at INSEAD and he speaks fluently English and German.
Thursday 23
12.25 - 12.55
The Next Decade of Public Health: Policy, Innovation and Global Challenges
Apollon Hall | Amalia Hotel
14.35 - 15.20
Clinical Trials in Europe: Competitiveness, Access and Innovation
Apollon Hall | Amalia Hotel
Programming Partner: HACRO
15.20 - 16.00
Unlocking Longevity: Health, Economy and Demographic Change
Apollon Hall | Amalia Hotel